Hepatitis C Virus Cell-Cell Transmission and Resistance to Direct-Acting Antiviral Agents
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatitis C Virus Cell-Cell Transmission and Resistance to Direct-Acting Antiviral Agents
Authors
Keywords
Hepatitis C virus, Antimicrobial resistance, Cell cultures, Viral transmission and infection, Viral load, Antibodies, Flow cytometry, RNA sequencing
Journal
PLoS Pathogens
Volume 10, Issue 5, Pages e1004128
Publisher
Public Library of Science (PLoS)
Online
2014-05-16
DOI
10.1371/journal.ppat.1004128
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Entry inhibitors and future treatment of hepatitis C
- (2014) Isabel Fofana et al. ANTIVIRAL RESEARCH
- HRas Signal Transduction Promotes Hepatitis C Virus Cell Entry by Triggering Assembly of the Host Tetraspanin Receptor Complex
- (2013) Laetitia Zona et al. Cell Host & Microbe
- Combination therapies with NS5A, NS3 and NS5B inhibitors on different genotypes of hepatitis C virus in human hepatocyte chimeric mice
- (2013) Niu Shi et al. GUT
- Isolate-dependent use of claudins for cell entry by hepatitis C virus
- (2013) Sibylle Haid et al. HEPATOLOGY
- An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission
- (2013) Alexander W. Tarr et al. HEPATOLOGY
- Early infection events highlight the limited transmissibility of hepatitis C virus in vitro
- (2013) Luke W. Meredith et al. JOURNAL OF HEPATOLOGY
- Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890
- (2013) Christophe Hézode et al. JOURNAL OF HEPATOLOGY
- NS5A inhibitors in the treatment of hepatitis C
- (2013) Jean-Michel Pawlotsky JOURNAL OF HEPATOLOGY
- Safety and Antiviral Activity of the HCV Entry Inhibitor ITX5061 in Treatment-Naive HCV-Infected Adults: A Randomized, Double-Blind, Phase 1b Study
- (2013) Mark S. Sulkowski et al. JOURNAL OF INFECTIOUS DISEASES
- Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
- (2013) M. T. Catanese et al. JOURNAL OF VIROLOGY
- Functional Analysis of Claudin-6 and Claudin-9 as Entry Factors for Hepatitis C Virus Infection of Human Hepatocytes by Using Monoclonal Antibodies
- (2013) I. Fofana et al. JOURNAL OF VIROLOGY
- Treatment decisions and contemporary versus pending treatments for hepatitis C
- (2013) Paul M. Trembling et al. Nature Reviews Gastroenterology & Hepatology
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current and Future Therapies for Hepatitis C Virus Infection
- (2013) T. Jake Liang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C
- (2013) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
- (2013) Edward J. Gane et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Monoclonal Anti-CD81 Antibody Produced by Genetic Immunization Efficiently Inhibits Hepatitis C Virus Cell-Cell Transmission
- (2013) Isabel Fofana et al. PLoS One
- Extent of HCV NS3 protease variability and resistance-associated mutations assessed by next generation sequencing in HCV monoinfected and HIV/HCV coinfected patients
- (2013) Barbara Bartolini et al. VIRUS RESEARCH
- Combination Treatment with Hepatitis C Virus Protease and NS5A Inhibitors Is Effective against Recombinant Genotype 1a, 2a, and 3a Viruses
- (2012) Judith M. Gottwein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment failure with new hepatitis C drugs
- (2012) Vincent Soriano et al. EXPERT OPINION ON PHARMACOTHERAPY
- The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination
- (2012) Muhammad N. Zahid et al. HEPATOLOGY
- Antiviral strategies in hepatitis C virus infection
- (2012) Christoph Sarrazin et al. JOURNAL OF HEPATOLOGY
- Host-targeting agents for prevention and treatment of chronic hepatitis C – Perspectives and challenges
- (2012) Mirjam B. Zeisel et al. JOURNAL OF HEPATOLOGY
- Perspectives and challenges of interferon-free therapy for chronic hepatitis C
- (2012) Christian M. Lange et al. JOURNAL OF HEPATOLOGY
- Evaluation of ITX 5061, a Scavenger Receptor B1 Antagonist: Resistance Selection and Activity in Combination With Other Hepatitis C Virus Antivirals
- (2012) Haihong Zhu et al. JOURNAL OF INFECTIOUS DISEASES
- Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
- (2012) Anna S. Lok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fresh Approaches to Anti-Infective Therapies
- (2012) C. Nathan Science Translational Medicine
- Cell-to-cell transmission of viruses
- (2012) Peng Zhong et al. Current Opinion in Virology
- Human Monoclonal Antibodies to a Novel Cluster of Conformational Epitopes on HCV E2 with Resistance to Neutralization Escape in a Genotype 2a Isolate
- (2012) Zhen-yong Keck et al. PLoS Pathogens
- Cell-Cell Transmission Enables HIV-1 to Evade Inhibition by Potent CD4bs Directed Antibodies
- (2012) Irene A. Abela et al. PLoS Pathogens
- Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus
- (2011) Jean-Michel Pawlotsky HEPATOLOGY
- Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy
- (2011) Alex Sigal et al. NATURE
- EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
- (2011) Joachim Lupberger et al. NATURE MEDICINE
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of Non–Small-Cell Lung Cancer with Erlotinib or Gefitinib
- (2011) Vince D. Cataldo et al. NEW ENGLAND JOURNAL OF MEDICINE
- The hepatitis C virus NS5A inhibitor (BMS-790052) alters the subcellular localization of the NS5A non-structural viral protein
- (2011) Choongho Lee et al. VIROLOGY
- In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435
- (2010) O. Lenz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fc block treatment, dead cells exclusion, and cell aggregates discrimination concur to prevent phenotypical artifacts in the analysis of subpopulations of tumor-infiltrating CD11b+ myelomonocytic cells
- (2010) Francois Kuonen et al. CYTOMETRY PART A
- Recombinant HCV Variants With NS5A From Genotypes 1–7 Have Different Sensitivities to an NS5A Inhibitor but Not Interferon-α
- (2010) Troels K.H. Scheel et al. GASTROENTEROLOGY
- Neutralizing Antibody-Resistant Hepatitis C Virus Cell-to-Cell Transmission
- (2010) C. L. Brimacombe et al. JOURNAL OF VIROLOGY
- Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system
- (2010) Christopher T Jones et al. NATURE BIOTECHNOLOGY
- Telaprevir for Previously Treated Chronic HCV Infection
- (2010) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- HIV Persistence and the Prospect of Long-Term Drug-Free Remissions for HIV-Infected Individuals
- (2010) D. Trono et al. SCIENCE
- Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C Virus
- (2010) L. Rong et al. Science Translational Medicine
- Increased HDL Cholesterol and ApoA-I in Humans and Mice Treated With a Novel SR-BI Inhibitor
- (2009) David Masson et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Production of Infectious Genotype 1b Virus Particles in Cell Culture and Impairment by Replication Enhancing Mutations
- (2009) Thomas Pietschmann et al. PLoS Pathogens
- Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs
- (2008) Judith M. Gottwein et al. HEPATOLOGY
- CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells
- (2008) J. Witteveldt et al. JOURNAL OF GENERAL VIROLOGY
- Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies
- (2008) J. Grove et al. JOURNAL OF VIROLOGY
- Avoiding the void: cell-to-cell spread of human viruses
- (2008) Quentin Sattentau NATURE REVIEWS MICROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started